![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » GSK Partners with Canadian Biotech Medicago on COVID-19 Vaccine
GSK Partners with Canadian Biotech Medicago on COVID-19 Vaccine
GlaxoSmithKline (GSK) has teamed up with Canadian biotech company Medicago to develop a COVID-19 vaccine.
The companies plan to launch a phase 1 clinical trial of the vaccine this month.
Medicago will contribute virus-like particles (VLPs) produced through recombinant DNA technology that stimulate an immune response to the coronavirus, and GSK will supply an adjuvant to boost the response.
Upcoming Events
-
21Oct